EBOS Group Limited
EBO.AXHealthcareASXMedical Distribution
Scan Results
Daily timeframeEBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. Valued at $3.28B, EBO.AX is a mid-cap name in its sector. It operates through Healthcare and Animal Care segments.
Market Cap
$3.28B
Beta
0.20
P/E (TTM)
15.51
P/E (Fwd)
13.11
EPS (TTM)
$1.03
EPS (Fwd)
$1.22
ROE
9.0%
ROA
3.6%
Cash
$261.2M
Total Debt
$1.85B
Free CF
$90.7M
52W Change
-53.3%
Annual Financials
Cash vs Debt
The company holds $261.2M in cash, though total debt stands at $1.85B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $90.7M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 9.0%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.6% is on the lower side, which is common in asset-heavy industries. Revenue has been uneven over recent years, ranging from $11.90B to $13.21B.
With a beta below 0.7, EBOS Group Limited typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. EBOS Group Limited carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence EBOS Group Limited's trajectory.